Kinetic resolutions and enantioselective transformations of 5- (acyloxy)pyrrolinones using Candida antarctica lipase B: Synthetic and structural aspects

Journal of Organic Chemistry

Volumn 64, Issue 26, 1999, Pages 9529-9537

  Cuiper, Agnes D ^a   Kouwijzer, Milou L C E ^b   Grootenhuis, Peter D J ^c   Kellogg, Richard M ^a   Feringa, Ben L ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b Molecular Design and Informatics   (Netherlands)

^c CombiChem ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 (ACYLOXY)PYRROLINONE DERIVATIVE; PYRROLIDINE DERIVATIVE; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ARTICLE; CANDIDA; CANDIDA ANTARCTICA; CHEMICAL REACTION KINETICS; ENZYME KINETICS; ENZYME MODIFICATION; ESTERIFICATION; MOLECULAR MODEL; NONHUMAN; SYNTHESIS;

EID: 0033601222     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo991062e     Document Type: Article

References (54)

1. Wong, C. H.; Whitesides, G. M. In Enzymes in Synthetic Organic Chemistry; Elsevier Science Ltd.: Oxford, U.K., 1994.
2. (a) Schmid, R. D.; Verger, R. Angew. Chem., Int. Ed. Engl. 1998, 37, 1608-1633.
3. (a) Klibanov, A. M. Chemtech 1986, 354-359.
4. (b) Klibanov, A. M. Acc. Chem. Res. 1990, 114-120.
5. (a) Santaniello, E.; Ferraboschi, P.; Grisenti, P.; Manzocci, A. Chem. Rev. 1992, 92, 1071-1140.
6. (b) Itoh, T.; Takagi, Y.; Tsukube, H. J. Mol. Catal. B: Enzymol. 1997, 3, 259-270.
7. (a) Gotor, V.; Limeres, F. L.; García, M. J.; Bayod, M.; Brieva, R. Tetrahedron: Asymmetry 1997, 8, 995-997.
8. (a) Hoff, B. A.; Waagen, V.; Anthonsen, T. Tetrahedron: Asymmetry 1996, 7, 3181-3186.
9. (a) García, M. J.; Rebolledo, F.; Gotor, V. Tetrahedron: Asymmetry 1993, 4, 2199-2110.
10. (b) Öhrner, N.; Orrenius, C.; Mattson, A.; Norin, T.; Hult, K. Enzyme Microb. Technol. 1996, 19, 328-331.
11. (c) Sánchez, V. M.; Rebolledo, F.; Gotor, V. Tetrahedron: Asymmetry 1997, 8, 37-40.
12. (d) Iglesias, L. E.; Sánchez, V. M.; Rebolledo, F.; Gotor, V. Tetrahedron: Asymmetry 1997, 8, 2675-2677.
13. (a) Jouin, P.; Castro, B. J. Chem. Soc., Perkin Trans. 1 1987, 1177.
14. (b) Ma, D.; Ma, J.; Ding, W.; Dai, L. Tetrahedron: Asymmetry 1996, 7, 2365.
15. (a) Klaver, W. J.; Hiemstra, H.; Speckamp, W. N. J. Am. Chem. Soc. 1989, 11, 2588.
16. (b) Casiraghi, G.; Spanu, P.; Rassu, G.; Pinna, L.; Ulgheri, F. J. Org. Chem. 1994, 59, 2906.
17. (c) Griffart-Brunet, D.; Langois, N. Tetrahedron Lett. 1994, 35, 119.
18. (d) Newcombe, N. J.; Ya, F.; Vijn, R. J.; Hiemstra, H.; Speckamp, W. N. J. Chem. Soc., Chem. Commun. 1994, 6, 767.
19. (e) Dittami, J. P.; Xu, F.; Qi, H.; Martin, M. W. Tetrahedron Lett. 1995, 36, 4201.
20. (f) Shiraki, R.; Sumino, A.; Tadano, K.; Ogawa, S. J. Org. Chem. 1996, 61, 2845.
21. (g) Iwasawa, N.; Maeyama, K. J. Org. Chem. 1997, 62, 1918.
22. Koot, W.-J.; Hiemstra, H.; Speckamp, W. N. J. Org. Chem. 1992, 57, 1059.
23. Deen van der, H.; Cuiper, A. D.; Hof, R. P.; Oeveren van, A.; Feringa, B. L.; Kellogg, R. M. J. Am. Chem. Soc. 1996, 118, 3801-3803.
24. (a) Uppenberg, J.; Hansen, M. T.; Patkar, S.; Jones, T. A. Structure 1994, 2, 293-308.
25. (b) Uppenberg, J.; Patkar, S.; Bergfors, T.; Jones, T. A. J. Mol. Biol. 1994, 235, 790-792.
26. (c) Uppenberg, J.; Öhrner, N.; Norin, M.; Hult, K.; Kleywegt, G. J.; Patkar, S.; Waagen, V.; Anthonsen, T.; Jones, T. A. Biochemistry 1995, 33, 16838-16851.
27. (a) Haeffner, F.; Norin, T.; Hult, K. Biophys. J. 1998, 74, 1251-1262.
28. (b) Orrenius, C.; Haeffner, F.; Rotticci, D.; Öhrner, N.; Norin, T.; Hult, K. Biocatal. Biotransform. 1998, 16, 1-15.
29. (c) Heinsman, N. W. J. T.; Orrenius, S. C.; Marcelis, C. L. M.; Sousa Teixeira de, A.; Franssen, M. C. R.; Padt van der, A.; Jongejan, J. A.; Groot de, A. E. Biocatal. Biotransform. 1998, 16, 145-162.
30. (d) Rotticci, D.; Haeffner, F.; Orrenius, C.; Norin, T.; Hult, K. J. Mol Catal. B: Enzymol. 1998, 5, 267-272.
31. (a) Mayo de, P.; Reid, S. T. Chem. Ind. (London) 1962, 1576.
32. (b) Lightner, D. A.; Bisacchi, G. S.; Norris, R. D. J. Am. Chem. Soc. 1976, 98, 2.
33. (c) Lightner, D. A.; Kirk, D. I.; Norris, R. D. Heterocycl. Chem. 1974, 11, 1097-1098.
34. Lombardi, P. Chem. Ind. 1990, 21, 708.
35. Cuiper, A. D.; Kellogg, R. M.; Feringa, B. L. Chem. Commun. 1998, 655-656.
36. QUANTA/CHARMm, version 4.0, Molecular Simulations Inc., Burlington, MA.
37. (a)Abola, E. E.; Bernstein, F. C.; Bryant, S. H.; Koezle, T. F.; Weng, J. Protein Data Bank. In Crystallographic Databases Content, Software Systems, Scientific Applications; Allen, F. H., Bergerhoff, G., Sievers, R., Eds.; Data Commission of the International Union of Crystallography: Bonn/Cambridge/Chester, 1987; pp 107-132.
38. (b) Bernstein, F. C.; Koezle, T. F.; Williams, G. J. B.; Meyer, Jr., E. F.; Brice, M. D.; Rodgers, J. R.; Kennard, O.; Shimanouehi, T.; Tasumi, M. The Protein Data Bank: a Computer-based Archival file for Macromolecular Structures. J. Mol. Biol. 1977, 112, 535-542.
39. The X-ray structure of 1a will be published in Acta Crystallogr. C.
40. The structure of the substrate-protein complex was previously optimized with CHARMm. From this structure, residues in close contact (cutoff = 5 Å) with the substrate were selected (selected residues: Gly39, Thr40, Gly41, Thr42, Ser47, Trp104, Ser105, Gln106, Gly107, Asp134, Thr138, Val154, Gln157, Ile189, Val190, His224, Leu227, Leu278, Ala281, Ala282, Ile285). The structure was edited manually: all peptidic CO and NH at the edges of the selected residues were removed and the hydrogens were added in their place for completeness. Atomic charges for the entire system (307 atoms) were obtained at the AM1 semiemperical level (Dewar, M. J. S.; Zoebisch, E. G.; Healy, E. F.; Steward, J. P. P. J. Am. Chem. Soc. 1985, 107, 3902) as implemented in the program Gaussian94 (Fritsch, M. J.; Trucks, G. W.; Schlegel, H. B.; Gill, P. M. W.; Johnson, B. G.; Robb, M. A.; Cheeseman, J. R; Keith, T. A.; Petersson, G. A.; Montgomery, J. A.; Raghavachari, K.; Al-Laham, M. A.; Zakrzewski, V. G.; Ortiz, J. V.; Foresman, J. B.; Ciolowski, J.; Stefanov, B. B.; Nanayakkara, A.; Challacombe, M.; Peng, C. Y.; Ayala, P. Y.; Chen, W.; Wong, M. W.; Andres, J. L.; Repogle, E. S.; Gomperts, R.; Martin, R. L.; Fox, D. J.; Binkley, J. S.; Defrees, D. J.; Baker, J.; Steward, J. J. P.; Head-Gordon, M.; Gonzalez, C.; Pople, J. A. GAUSSIAN 94, Revision E.2; Gaussian, Inc.: Pittsburgh, PA, 1995) .
41. The structure of the substrate-protein complex was previously optimized with CHARMm. From this structure, residues in close contact (cutoff = 5 Å) with the substrate were selected (selected residues: Gly39, Thr40, Gly41, Thr42, Ser47, Trp104, Ser105, Gln106, Gly107, Asp134, Thr138, Val154, Gln157, Ile189, Val190, His224, Leu227, Leu278, Ala281, Ala282, Ile285). The structure was edited manually: all peptidic CO and NH at the edges of the selected residues were removed and the hydrogens were added in their place for completeness. Atomic charges for the entire system (307 atoms) were obtained at the AM1 semiemperical level (Dewar, M. J. S.; Zoebisch, E. G.; Healy, E. F.; Steward, J. P. P. J. Am. Chem. Soc. 1985, 107, 3902) as implemented in the program Gaussian94 (Fritsch, M. J.; Trucks, G. W.; Schlegel, H. B.; Gill, P. M. W.; Johnson, B. G.; Robb, M. A.; Cheeseman, J. R; Keith, T. A.; Petersson, G. A.; Montgomery, J. A.; Raghavachari, K.; Al-Laham, M. A.; Zakrzewski, V. G.; Ortiz, J. V.; Foresman, J. B.; Ciolowski, J.; Stefanov, B. B.; Nanayakkara, A.; Challacombe, M.; Peng, C. Y.; Ayala, P. Y.; Chen, W.; Wong, M. W.; Andres, J. L.; Repogle, E. S.; Gomperts, R.; Martin, R. L.; Fox, D. J.; Binkley, J. S.; Defrees, D. J.; Baker, J.; Steward, J. J. P.; Head-Gordon, M.; Gonzalez, C.; Pople, J. A. GAUSSIAN 94, Revision E.2; Gaussian, Inc.: Pittsburgh, PA, 1995) .
42. Grootenhuis, P. D. J.; Galen van, P. Correlation of Binding Affinities with Non-bonded Interaction Energies of Thrombin-Inhibitor Complexes. Acta Crystallogr. 1995, D51, 560-566.
43. The absolute configurations were determined by X-ray analysis of a pyrrolinone-iron carbonyl complex (for 1a) and by a new CD method (for 1a-e): Cuiper, A. D.; Brzostowska, M.; Gawronski, J. K.; Smeets, W. J. J.; Spek, A. L.; Hiemstra, H.; Kellogg, R. M.; Feringa, B. L. J. Org. Chem. 1999, 64, 2567-2570.
44. (a) Morrison, J. D. In Asymmetric Synthesis; Academic Press: New York, 1983; Vol. 1, p 3.
45. (b) Eliel, E. L.; Wilen, S. H. Stereochemistry of Organic Compounds; Wiley-Interscience: New York, 1994; p 414.
46. (c) Ward, R. S. Tetrahedron: Asymmetry 1995, 6, 1475.
47. (d) Brand, S. A.; Jones, M. F.; Rayner, C. M. Tetrahedron Lett. 1995, 36, 8493-8496.
48. (e) Tan, D. S.; Günter, M. M.; Drueckhammer, D. G. J. Am. Chem. Soc. 1995, 117, 9093-9094.
49. (f) Stürmer, R. Angew. Chem., Int. Ed. Engl. 1997, 36, 1173-1174.
50. Kazlauskas, R. J.; Weissfloch, A. N. E.; Rappaport, A. T.; Cuccia, L. A. J. Org. Chem. 1991, 56, 2656-2665.
51. Prelog, V. Pure Appl. Chem. 1964, 9, 119-130.
52. Norin, M.; Hult, K.; Mattson, A.; Norin, T. Biocatalysis 1993, 7, 131-147.
53. Norin, M.; Haeffner, F.; Achour, A.; Norin, T.; Hult, K. Protein Sci. 1998, 3, 1493-1503.
54. Entry ILBS.